Diabetes Health

The C-Peptide Response to Glucose Test with 6 specimens measures pancreatic beta cell activity and insulin secretion at six timed intervals. Tracking C-peptide levels across multiple points provides a detailed profile of insulin production, glucose regulation, and metabolic health, supporting assessment of insulin resistance, hypoglycemia, diabetes risk, and overall endocrine function.

The C-Peptide Response to Glucose Test with 7 specimens measures pancreatic beta cell activity and insulin secretion across seven timed intervals. Monitoring C-peptide changes over multiple collections provides detailed insight into insulin production, glucose regulation, and metabolic balance, supporting evaluation of diabetes risk, hypoglycemia, insulin resistance, and endocrine system health.

The C-Peptide Response to Glucose Test with 9 specimens measures pancreatic beta cell activity and insulin secretion across nine timed intervals. Tracking C-peptide patterns provides detailed insight into insulin production, glucose regulation, and metabolic health, supporting the detection of insulin resistance, diabetes risk, hypoglycemia, and overall endocrine function.

The Cardio IQ™ HDL Cholesterol Test evaluates levels of high-density lipoprotein cholesterol, the “good” cholesterol that plays a critical role in heart health. Adequate HDL supports the removal of excess cholesterol from the bloodstream, reducing plaque buildup in arteries. This test provides valuable insight into cardiovascular wellness, lipid balance, and overall risk of heart disease when combined with other lipid panel results.

The Hemoglobin A1c (HbA1c) test measures the average blood glucose level over the past two to three months. It provides valuable information about long-term blood sugar control in individuals with diabetes.

The Cardio IQ™ Triglycerides Test measures triglyceride levels in the blood, an important marker of lipid metabolism and cardiovascular health. Elevated triglycerides are linked to increased risk of heart disease, pancreatitis, and metabolic syndrome. Physicians use this test to assess risk factors, monitor therapy response, and guide lifestyle or treatment decisions, often as part of a broader lipid or heart health evaluation.

The HDL Cholesterol Test measures high-density lipoprotein cholesterol, often called “good” cholesterol, which helps remove excess cholesterol from the bloodstream. Higher HDL levels are linked to a lower risk of heart disease, while low levels may increase cardiovascular risk. Doctors use this blood test as part of a lipid panel to assess heart health, evaluate risk factors, and guide lifestyle or treatment strategies for cardiovascular disease prevention.

The Copeptin Test detects copeptin levels in blood as a biomarker of vasopressin release, fluid regulation, and systemic stress. Abnormal results may indicate heart failure, myocardial infarction, kidney dysfunction, or endocrine imbalance. This test provides insight into cardiovascular health, water balance, and systemic conditions influenced by stress response and vasopressin activity.

The Glucagon Test evaluates hormone levels that regulate glucose by stimulating the liver to release stored sugar. Elevated or low glucagon may indicate diabetes, hypoglycemia, metabolic disorders, or pancreatic disease. This test provides insight into endocrine activity, glucose balance, and systemic health conditions related to energy metabolism and hormonal function.

The Glucose Test measures blood sugar levels to evaluate energy metabolism and screen for diabetes or prediabetes. Abnormal glucose may indicate hyperglycemia, hypoglycemia, or metabolic disorders. Doctors use this test during routine exams, to investigate symptoms like fatigue, excessive thirst, or frequent urination, and to monitor treatment for diabetes. It provides essential insight into how the body regulates blood sugar and overall metabolic health.

The Glucose Tolerance Test, 2 Specimens, 75g evaluates the body’s glucose metabolism by testing fasting and one-hour blood glucose levels after ingestion of a 75-gram glucose solution. It is an important diagnostic tool for identifying impaired glucose regulation, prediabetes, and type 2 diabetes. This test helps reveal early changes in insulin sensitivity and overall metabolic function.

The Glucose Tolerance Test, 3 Specimens, 75g evaluates blood sugar at fasting, 1-hour, and 2-hour intervals following a 75-gram glucose drink. It is a key diagnostic tool for identifying impaired glucose regulation, prediabetes, and type 2 diabetes. Measuring glucose response at multiple times allows clinicians to assess insulin function, detect early metabolic dysfunction, and better understand progression to diabetes.

The Glucose Tolerance Test, 4 Specimens evaluates blood glucose at fasting, 1-hour, 2-hour, and 3-hour intervals after a glucose drink. This test is an important tool for diagnosing or screening for prediabetes, type 2 diabetes, and impaired glucose metabolism. Measuring glucose response across multiple specimens provides valuable data on insulin function, carbohydrate handling, and overall metabolic health.

The Glucose Tolerance Test, 5 Specimens evaluates glucose response at fasting, 1, 2, 3, and 4 hours after a standard glucose drink. By analyzing multiple specimens, it identifies impaired glucose tolerance, prediabetes, and type 2 diabetes. The test provides clinicians with extensive information on insulin function, glucose regulation, and the progression of metabolic disorders that affect long-term health outcomes.

The Glucose Tolerance Test, 6 Specimens evaluates blood sugar response at fasting and hourly intervals up to 5 hours after ingestion of a glucose solution. This test provides a comprehensive assessment of glucose metabolism, helping detect impaired glucose tolerance, prediabetes, and diabetes risk. Measuring six specimens reveals detailed patterns of insulin function, metabolic regulation, and progression to chronic disease.

The Glucose Tolerance Test, 7 Specimens evaluates blood sugar at fasting and six hourly intervals after ingestion of a glucose solution, spanning 6 hours of monitoring. It is used to identify prediabetes, diabetes, and impaired glucose regulation. By analyzing seven specimens, the test reveals patterns in insulin function, metabolic regulation, and progression of abnormalities that impact long-term health.

The Fasting and Gestational Glucose Test, 135 Cutoff evaluates fasting glucose and post-load blood sugar one hour after a 50-gram glucose challenge. A 135 mg/dL cutoff helps identify women at increased risk for gestational diabetes who may require follow-up testing. This test offers valuable information about maternal carbohydrate metabolism, insulin activity, and abnormal glucose regulation in pregnancy.

The Fasting and Gestational Glucose Test, 140 Cutoff evaluates both fasting glucose and blood sugar one hour after a 50-gram glucose drink. A result above the 140 mg/dL cutoff identifies women at risk for gestational diabetes who may need follow-up testing. This screening tool highlights maternal carbohydrate metabolism, insulin activity, and abnormal glucose regulation during pregnancy.

 The 2 Hour Fasting and Postprandial Glucose Test is a diagnostic procedure that measures the body's ability to metabolize glucose (sugar) and respond to insulin. It involves taking two blood samples: one after an overnight fast and another two hours after consuming a meal.

The Gestational Glucose Screen, 50g, 135 Cutoff evaluates maternal blood sugar one hour after a 50-gram glucose drink to screen for gestational diabetes risk. A threshold of 135 mg/dL helps determine the need for follow-up glucose tolerance testing. This test offers important information on maternal carbohydrate metabolism, insulin function, and potential complications related to abnormal glucose regulation in pregnancy.

The Gestational Glucose Screen, 50g, 140 Cutoff evaluates blood glucose one hour after a 50-gram glucose drink to screen for gestational diabetes risk. The 140 mg/dL threshold identifies women who may need follow-up testing with an oral glucose tolerance test. This screening tool provides insight into maternal carbohydrate metabolism, insulin function, and potential pregnancy-related health concerns.

The Glucose Plasma Test measures the amount of glucose in the blood to assess how the body regulates sugar. Abnormal results may indicate diabetes, prediabetes, hypoglycemia, or other metabolic disorders. Doctors order this test for patients with symptoms like fatigue, excessive thirst, or frequent urination. It is also commonly used for routine health screening, monitoring diabetes treatment, and guiding lifestyle or medication adjustments.

The Glucose Random Test evaluates glucose levels in the blood without requiring fasting, making it useful for detecting abnormal sugar regulation. Elevated or low results may suggest diabetes, prediabetes, or hypoglycemia. This test supports assessment of metabolic function, carbohydrate processing, and systemic health, offering insight into symptoms like thirst, frequent urination, or unexplained fatigue.

 The Glutamic Acid Decarboxylase-65 (GAD-65), IA-2, and Insulin Autoantibodies Test is a diagnostic tool employed to assess autoantibodies directed against specific proteins involved in the regulation of insulin production. This test plays a crucial role in the identification and monitoring of autoimmune conditions, particularly Type 1 diabetes, as well as providing insights into the risk of developing diabetes in susceptible individuals.

The Glutamic Acid Decarboxylase-65 (GAD65) Antibody Test detects antibodies against the GAD65 enzyme, often linked to autoimmune type 1 diabetes and latent autoimmune diabetes in adults (LADA). Positive results indicate immune-related damage to insulin-producing beta cells. Doctors use this test to distinguish type 1 from type 2 diabetes, evaluate unexplained hyperglycemia, and assess risk in patients with suspected autoimmune endocrine disorders.